H2U Corp
Last funding round
Raised
$10,000,000
Round
Series B
Investors
Led by Standard Foods,GrandTech C.G. Systems (Taiwan)
Startup details
H2U is dedicated to promoting Lifestyle Medicine and employs AI data insights to deliver precision nutrition, preventive medicine, and holistic health solutions. The company integrates digital health management, personalized medical checkup plans, precise nutritional science, individualized sports prescriptions, and corporate health promotion in its digital health ecosystem platform.
Investment details
Founder Stories
Dr. Sterghois Moschos, PulmoBioMed
Recent 5 from Healthcare
Jul2024
1
3 weeks ago
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Founders
David Fellows
In News
NewsnReleases
DirectorsTalk Interviews
2
3 weeks ago
Scotland-based MI:RNA Diagnostics specializes in early disease detection technology for animals using microRNA biomarkers.
Founders
Eve Hanks
In News
businessInsider
3
3 weeks ago
Colorado-based Hummingbird Healthcare streamlines patient access and operational efficiency for healthcare providers.
Founders
Jeremy Schwach
In News
Hitconsultant
4
3 weeks ago
Gurugram-based Amocare offers premium intimate wellness products with a focus on natural solutions.
Founders
Prabhat Maheshwari
In News
Entrackr
5
3 weeks ago
New York-based K Health provides AI-driven chatbot for patients before consulting physicians.
Founders
Allon Bloch
In News
Yahoo Finance
Recent 5 from Taiwan
Jul2024
1
4 weeks ago
Taiwan-based Cooby integrates WhatsApp with CRM systems to streamline sales workflows.
Founders
Wen Shaw
In News
GlobeNewswire News Room
2
1 month ago
Taipei-based XREX is a blockchain-enabled financial institution offering enterprise-grade banking services to SMBs in emerging markets and novice-friendly financial services globally.
Founders
Wayne Huang,
Winston Hsiao
In News
PR Newswire
3
4 months ago
Taiwan-based iKala offers AI-driven cloud services and marketing technology to enterprises, including Fortune 500 firms.
Founders
Sega Cheng
In News
PR Newswire
4
5 months ago
Taipei-based Anbogen Therapeutics is a clinical-stage biotechnology company developing precision anti-cancer drugs.
Founders
TsungKai (Angus) Wu
In News
FinSMEs
PR Newswire